Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Credit agrmnt [a] Director departure Inv. presentation Quarterly results Acq. announced
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/08/2019 |
4
| Pina Kenneth (SVP, GC,Compliance Off & Sec) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 417 shares
@ $0.449, valued at
$187.2 |
|
08/10/2018 |
4
| Pina Kenneth (SVP, GC & Compliance Off.) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 411 shares
@ $1.86, valued at
$764.5 |
|
08/10/2018 |
4
| Whaley Glenn (VP of Fin, PAO & Controller) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 84 shares
@ $1.86, valued at
$156.2 |
|
08/10/2018 |
4
| Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 685 shares
@ $1.86, valued at
$1.3k
|
|
08/10/2018 |
4
| Smith Angus W. (SVP, CBO & Principal Fin Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 282 shares
@ $1.86, valued at
$524.5 |
|
07/27/2018 |
4
| Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 11,982 shares
@ $2.53, valued at
$30.3k
|
|
05/23/2018 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
05/23/2018 |
4
| Leone John R (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
05/23/2018 |
4
| LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
05/23/2018 |
4
| LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
04/09/2018 |
4
| Pina Kenneth (SVP, GC & Compliance Off.) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 446 shares
@ $2.74, valued at
$1.2k
|
|
03/16/2018 |
4
| Smith Angus W. (SVP, Chief Bus Off & PFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 5,000 shares
@ $0 Granted 15,000 options to buy
@ $2.46, valued at
$36.9k
|
|
03/16/2018 |
4
| Pina Kenneth (SVP, GC & Compliance Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 5,000 shares
@ $0 Granted 15,000 options to buy
@ $2.46, valued at
$36.9k
|
|
03/16/2018 |
4
| Whaley Glenn (Interim VP Fin, PAO & Controll) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 2,600 shares
@ $0 Granted 7,800 options to buy
@ $2.46, valued at
$19.2k
|
|
03/16/2018 |
4
| Sedor John A (Chairman of the Board & CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 18,000 shares
@ $0 Granted 64,000 options to buy
@ $2.46, valued at
$157.4k
|
|
11/17/2017 |
4
| LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
11/17/2017 |
4
| LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
11/17/2017 |
4
| Leone John R (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
11/17/2017 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
08/09/2017 |
4
| Golembiewski Michael Joseph (VP Finance, Controller, CAO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 3,300 shares
@ $0 Granted 10,000 options to buy
@ $2.92, valued at
$29.2k
|
|
08/09/2017 |
4
| Pina Kenneth (SVP, Gen Counsel & Comp Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 6,000 shares
@ $0 Granted 18,000 options to buy
@ $2.78, valued at
$50k
|
|
08/09/2017 |
4
| Miao Graham G (President and CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 6,667 shares
@ $0 Granted 20,000 options to buy
@ $2.78, valued at
$55.6k
|
|
08/09/2017 |
4
| Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 10,000 shares
@ $0 Granted 30,000 options to buy
@ $2.78, valued at
$83.4k
|
|
07/31/2017 |
4
| Miao Graham G (President and CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 8,132 shares
@ $3.15, valued at
$25.6k
|
|
07/31/2017 |
4
| Sedor John A (Board Chairman and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Paid exercise price by delivering 13,293 shares
@ $3.15, valued at
$41.9k
|
|
01/17/2017 |
4
| Pina Kenneth (S VP, Gen Counsel and Comp Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC. |
11/22/2016 |
4
| LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC. |
11/07/2016 |
4
| Miao Graham G (PRESIDENT AND CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC. |
11/07/2016 |
4
| Sedor John A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC. |
05/31/2016 |
4
| Konidaris Tasos (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 40,000 options to buy
@ $0.45, valued at
$18k
|
|
05/31/2016 |
4
| ELMS STEVE (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Bought 40,000 options to buy
@ $0.45, valued at
$18k
|
|
05/11/2016 |
4
| Sedor John A (Interim CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 210,000 options to buy
@ $0.52, valued at
$109.2k
|
|
02/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/29/2016 |
4
| Golembiewski Michael Joseph (VP Finance, Controller, CAO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns:
| Granted 65,000 options to buy
@ $2.14, valued at
$139.1k
|
|
|
|
|